Navigation Links
GOP's Big Pharma Protection to Cost NC Taxpayers "Hundreds of Millions"
Date:4/14/2011

RALEIGH, N.C., April 14, 2011 /PRNewswire-USNewswire/ -- Attorney General Roy Cooper warned the House Special Select Committee on Tort Reform today that a measure giving immunity to pharmaceutical companies could cost North Carolina taxpayers what one legislator described as "hundreds of millions of dollars."

Still, the GOP-controlled committee, led by Rep. Johnathan Rhyne, approved the controversial measure.  HB 542 could go to the House floor for a vote next week.

The stunning exchange occurred when Rep. Jennifer Weiss floated an amendment to remove the immunity measure for pharma companies that sell harmful drugs.  A member of Attorney General Cooper's staff then stood and expressed the concerns of the NC Department of Justice.  The AG's office later put those concerns -- related to Medicaid and the State Health Plan as well as consumer recovery -- into writing:

"North Carolina taxpayers and consumers could lose millions in legal settlements won because of illegal drug marketing and other violations if House Bill 542 becomes law ... North Carolina could become only the second state in the country where pharmaceutical manufacturers could be allowed to do or say anything about a drug as long as it has basic FDA approval."

Rep. Rhyne acknowledged talking to Attorney General Cooper, but brushed off the concerns with what consumer advocates argued was a dangerous misreading of a law in Michigan, the only state to have passed the extreme legislation under consideration in North Carolina.

"Republican leaders in the House are siding with corporate interests over everyday taxpayers," said Dick Taylor of the NC Advocates for Justice.  "That Republicans would choose to cost the state hundreds of millions of dollars to help pharmaceutical companies during such hard economic times is beyond perplexing.  

But even more disturbing is the fact that under this bill, North Carolinians -- like people in Michigan, but unlike the citizens of every other state -- would be totally unable to recover damages in cases of death or injury due to bad drugs.  The bill benefits multinational drug companies at the expense of North Carolina consumers, and does nothing to help the North Carolina economy."

Under Rep. Rhyne's bill, drug companies could not be sued by those harmed by defective and dangerous drugs unless the company obtained FDA approval by fraud or bribery.  Even if the product is later found to be harmful or deadly, the drug manufacturer -- so long as it had FDA approval -- cannot be held liable.  

For more information, please contact Todd(at)ncaj(dot)com. Follow our news on Facebook http://www.facebook.com/pages/NC-Law-and-Politics/191212774245068 and on our website http://www.LetJuriesDecide.com.


'/>"/>
SOURCE NC Advocates for Justice
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp.
2. Beacon Announces Agreement With New Fortune 500 Pharmaceutical Client
3. Novis Pharmaceuticals Celebrates Four Years With New Website Launch
4. Merz Pharmaceuticals Joins Patient Advocates to Raise Awareness of Cervical Dystonia and Blepharospasm
5. Patients -- Not ERs and Big Pharma -- Need Protection
6. Mpex Pharmaceuticals, Inc. to be Acquired by Axcan
7. NCPA Backs Bill to Enhance Pharmacy Competition; Help Level Playing Field for Independent Community Pharmacists
8. Talyst Signs Vendor Agreement With H. D. Smith to Provide Quality- and Patient Safety-Enhancing Pharmacy Automation Solutions
9. PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial
10. ePharmaSolutions Launches Major Release of Its Global Safety Letter Distribution and Tracking Application in More Than 90 Countries
11. Cephalon Lodges Bidders Statement for A$167 Million Offer for ChemGenex Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2017)... , June 1, 2017 Nutriceutical Holdings (NH), ... Recommended Solutions (VRS), and KD Pharma Group have decided ... Holdings by KD Pharma Group. KD Pharma Group will ... option to acquire the entire company. "We ... They are committed to growing the NH companies by ...
(Date:5/30/2017)... , May 30, 2017 Hill-Rom Holdings, Inc. (NYSE: ... Annual Global Healthcare Conference on Tuesday, June 13, 2017, in ... Greisch , Hill-Rom,s president and chief executive officer, is scheduled ... live audio webcast can be accessed at http://ir.hill-rom.com/events.cfm . ... of the live event through September 13, 2017. ...
(Date:5/29/2017)... -- Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), ... selection of stem cells, today provided a corporate update ... March 31 st , 2017. "We ... quarter of 2017," said Dr. Shai Yarkoni, Chief Executive ... of the first blood cancer patient in the recently ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... June 20, 2017 , ... Connance, a leading provider of ... how predictive analytics drive reimbursement optimization, with a focus on denial management and ... , “The traditional approach to denied and underpaid claims leaves money on the ...
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, ... published a new eBook titled “ 5 Questions to Ask Before Entering the ... on the Genetic Test Evaluation (GTE) team, the book explores the various types ...
(Date:6/20/2017)... ... June 20, 2017 , ... HOUSTON – Brazos ... and a host of new options for today’s modern senior. Brazos Towers at ... active, independent lifestyle they love while offering them the services to support that lifestyle ...
(Date:6/20/2017)... , ... June 20, 2017 , ... ... disease in Cincinnati, OH for leading-edge care, whether or not they have ... dentistry. Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue ...
(Date:6/20/2017)... MA (PRWEB) , ... June 20, 2017 , ... ... (IPI) Clinical Innovation Catalyst program focused on finding product improvements that ... tubes placed in their throats when they need help breathing or to provide ...
Breaking Medicine News(10 mins):